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Objectives
 Review recommendations from recently published clinical
guidelines
 Discuss implications for clinical practice using a case-based
approach

Guidelines for Review
 American Diabetes 2015 Standards of Care
 USPSTF Screening for Thyroid Dysfunction
 USPSTF Screening for Carotid Artery Stenosis
 American College of Physicians Diagnosis of OSA
 American Academy of Pediatrics Fluoride Use in Children
 Advisory Committee on Immunization Practices
Pneumococcal Immunization Updates

American Diabetes 2015
Standards of Care

Section 2: Classification and
Diagnosis of Diabetes
 BMI cut point for screening overweight and obese Asian
Americans for prediabetes and type 2 diabetes changed from
25 kg/m2 to 23 kg/m2

Section 4: Foundations of Care:
Education, Nutrition, Physical Activity,
Smoking Cessation, Psychosocial
Care, and Immunization
 Limit time spent being sedentary to < 90 minutes at a time
 E-cigarettes not supported as an alternative to smoking
 Immunization recommendations updated to include
recommendations for PCV13 and PPSV23

Section 6: Glycemic Targets
 Fasting blood glucose target: 80-130 mg/dL
(previously 70-130 mg/dL)
 New recommendations to assess readiness for continuous
glucose monitoring (CGM)

Section 7: Approaches to Glycemic
Treatment
 Algorithm updated to reflect all currently available therapies

FDA Approved DM2 Medications
 SGL2 Inhibitors
 Dapagliflozen (January 2014)
 Empagliflozen (August 2014)

 GLP1 Receptor Agonists
 Abliglutide (April 2014)
 Dulaglutide (April 2014)

Section 8: Cardiovascular Disease
and Risk Management
 Diastolic blood pressure goal: 90 mmHg for most people with
diabetes and hypertension
 Statin treatment recommendations based on 2013 American
College of Cardiology/American Heart Association guidelines
 Screening lipid profile recommended at diagnosis, age 40,
and “periodically thereafter”

Section 9: Microvascular
Complications and Foot Care
 Foot exam at every visit for patients with insensate feet, foot
deformities, or a history of foot ulcers

Section 11: Children and
Adolescents
 A target A1c of <7.5% is recommended, though
individualization is encouraged

Section 12: Management of
Diabetes in Pregnancy
 New section with recommendations related to pregnancy and
diabetes, including preconception counseling, medications,
blood glucose targets, and monitoring

JM
 74 year old female
 PMH: DM2, HTN, HL,
osteoporosis
 Medications: metformin,
glipizide, lisinopril,
atorvastatin, ibandronate,
calcium/vitamin D
 3 month follow up visit

JM
 Fasting blood glucose log

Date

Fasting Blood Glucose

June 1

72

June 2

104

June 3

79

June 4

97

June 5

81

What would you do next?
(choose all that apply)
A)
B)
C)
D)

Tell her that her diabetes is very well controlled
Review signs/symptoms of hypoglycemia
Discontinue glipizide
Discontinue metformin and glipizide

What would you do next?
(choose all that apply)
A)
B)
C)
D)

Tell her that her diabetes is very well controlled
Review signs/symptoms of hypoglycemia
Discontinue glipizide
Discontinue metformin and glipizide

Summary
 Diastolic blood pressure and cholesterol guidelines updated
 Lower end of fasting blood glucose target adjusted to 80
mg/dL
 Focus on individualization and patient-centered care

USPSTF Screening for
Thyroid Dysfunction

U.S. Preventive Services Task
Force 2015 Recommendation

U.S. Preventive Services Task
Force 2004 Recommendation

USPSTF Screening for
Carotid Artery Stenosis

U.S. Preventive Services Task
Force 2014 Recommendation

U.S. Preventive Services Task
Force 2007 Recommendation

American College of
Physicians Diagnosis of OSA

 Recommendation 1: ACP Recommends a sleep
study for patients with unexplained daytime
sleepiness
 Grade: weak recommendation, low-quality
evidence

 Recommendation 2: ACP recommends
polysomnography for diagnostic testing in patients
suspected of obstructive sleep apnea. ACP
recommends portable sleep monitors in patients
without serious comorbidities as an alternative to
polysomnography when polysomnography is not
available for diagnostic testing.
 Grade: weak recommendation, moderate quality
evidence

ACP Recommendations for OSA
 Increased emphasis on diagnostic testing for unexplained
daytime sleepiness
 Portable monitors may be used in low risk patients
 Utility of portable monitors for diagnosing OSA in patients
with comorbid conditions, such as CHF or COPD, unknown

Case: SJ

“I feel so tired
during the day,
even when I get
a lot of sleep.”

 34 year old female
 PMH: obesity, gestational diabetes
 SH: Lives with husband and 1 year
old child

Case: SJ
 TSH, CBC, and Lyme’s tests all
normal
 Sleep hygiene has not decreased
fatigue

What would you do next?
A) Order a sleep study
B) Tell her to drink more coffee
C) Encourage close follow up and consider further testing if
symptoms progress or do not improve

What would you do next?
A) Order a sleep study
B) Tell her to drink more coffee
C) Encourage close follow up and consider further testing if
symptoms progress or do not improve

Daytime Sleepiness
 Sleep study warranted for unexplained daytime sleepiness

Sleepcenter.org

American Academy of
Pediatrics Fluoride Use in
Children

 Dental caries are the most common chronic
disease of childhood
 Caries (acid produced by bacteria erodes tooth
enamel) are preventable
 Fluoride has proven effectiveness to decrease
dental caries

Fluoride Modalities

Fluoride Use in Caries Prevention
 Perform oral health risk assessments on all children
beginning at 6 months of age
 Assess a child’s exposure to fluoride and determine the need
for supplements
 Understand indications for fluoride varnish
 Advocate for water fluoridation in the local community

Oral Health Risk Tools Available

Brightfutures.aap.org

Advisory Committee on
Immunization Practices
Pneumococcal Immunization
Updates

www.eziz.org

Advisory Committee on
Immunization Practices Recommendations for PCV13
Vaccine
All adults 65 years of age or older receive a dose
of PCV13 followed by a dose of PPSV23 6-12
months later
Adults over age 65 who have already received
PPSV23 at age 65 and older can have PCV13 in
12 months

Recommendations for Age 65 or Older

www.eziz.org

Recommendations for Age 19 or Older

www.eziz.org

Case: RM

“I just saw a
commercial about
some other
pneumonia shot.”

 67 year old female
 PMH: DM2, HTN, HL
 Received PPSV23 7 months ago

What would you tell her?
A) You have already been immunized for pneumonia and do
not need another vaccine
B) You can receive PCV13 today
C) You should return in 5 months for PCV13

What would you tell her?
A) You have already been immunized for pneumonia and do
not need another vaccine
B) You can receive PCV13 today
C) You should return in 5 months for PCV13

Case
 37 year old male
 PMH: Seasonal Allergies,
Current smoker

What would you tell him?
He doesn’t meet criteria for either pneumonia vaccine
He should have the new pneumonia vaccine, PCV13,
followed by PPSV23 in one year
C) He should be immunized with PPSV23 today
D) He should have PPSV23 today, followed by PCV13 in one
year
A)
B)

What would you tell him?
He doesn’t meet criteria for either pneumonia vaccine
He should have the new pneumonia vaccine, PCV13,
followed by PPSV23 in one year
C) He should be immunized with PPSV23 today
D) He should have PPSV23 today, followed by PCV13 in one
year
A)
B)

Summary
 Minimum FBG target changed to 80 mg/dL
 Sleep studies recommended for those with unexplained
daytime sleepiness
 Oral health risk tools and fluoride may help prevent dental
caries
 Patients over the age of 65 need PPV13 and PPSV23
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